Maximal Oxygen Consumption Requirements in Professional North American Ice Hockey.

ABSTRACT: Ferland, P-M, Marcotte-L'Heureux, V, Roy, P, Carey, V, Charron, J, Lagrange, S, Leone, M, and Comtois, AS. Maximal oxygen consumption requirements in professional North American ice hockey. J Strength Cond Res 35(4): 1586-1592, 2021-This study was designed to measure preseason on-ice relative V̇o2max of professional ice-hockey players (n = 101 National Hockey League [NHL], 42 American Hockey League [AHL], 4 East Coast Hockey League [ECHL], and 15 Canadian Hockey League [CHL]) throughout 17 years and compare it between generations, league level, and position, and to verify if it was related to season and NHL career statistics. Relative V̇o2max was measured on ice with a portable metabolic analyzer (K4b2, Cosmed, Rome) with full hockey equipment, except for the helmet with either the Skating Multistage Aerobic Test or the 30-15 intermittent ice test tests. Relative V̇o2max results from both tests were compared between players of the same generation with an independent-samples T-test and were not significantly different. A one-way analysis of variance and post hoc pairwise tests were performed to detect significant differences between groups. Pearson correlations (two-tailed) were also performed between selected variables. All statistical significance was set at p < 0.05. Results show that there are no significant differences for relative V̇o2max between generations (2001-2003 vs. 2006 vs. 2015-2017), league level (NHL vs. AHL vs. ECHL vs. CHL), and position (winger, center, and defense), other than the ECHL being lower. There are also no significant relationships between V̇o2max values and hockey season and NHL career statistics. Thus, the results show that there is a minimal relative V̇o2max requirement to play North American ice hockey at the elite level (55.9 ± 5.2 ml·kg-1·min-1; n = 162). Future research should be directed toward comparing V̇o2max of elite and amateur ice-hockey players to confirm the minimal relative V̇o2max requirement to play North American ice hockey at the elite level.

Contrast Training Generates Post-Activation Potentiation and Improves Repeated Sprint Ability in Elite Ice Hockey Players.

The purpose of this study was to measure the generating effects of Contrast Training (CT) on 6-hour post-activation potentiation (PAP) and its influence on jumping and on on-ice repeated sprint performance in ice hockey players. Forty-one participants were divided in two groups: experimental (EG) and control group (CG). The EG followed the CT PAP protocol which consisted of 5 sets of 5 half inertia back squat superset with 6 squat jumps. The effects of PAP were measured with the vertical countermovement jump (CMJ), stationary broad jump (BJ) and 9 repeated on ice 40-meter maximal sprints with hockey equipment. Results showed that the PAP generated by the CT protocol had no significant impact (p ≥ 0.05) on CMJ, BJ, blood lactate concentration, heart rate peak and rated perceived exertion as EG and CG group presented no significant differences in improvement. However, results show that there was a significant improvement (p < 0.05) for the EG in the total sprint time (-5.5 ± 2.6%; 56.2 ± 4.7 to 53.1 ± 3.9sec) mean sprint speed (+5.9 ± 3.0%; 6.4 ± 0.5 to 6.8 ± 0.5m/s) and in 1st sprint speed (+7.4% ± 5.9; 7.3 ± 0.7 to 7.8 ± 0.6m/s), but not for the CG (-1.4 ± 5.1%; 58.0 ± 5.4 to 57.2 ± 6.4sec), (+1.7 ± 5.1 %; 6.3 ± 0.6 to 6.4 ± 0.6m/s) and (+1.9 ± 7.7%; 6.9 ± 0.7 to 7.0 ± 0.7m/s) respectively. Thus, results show that the CT protocol utilized in this study generated PAP which had an acute effect on the on-ice hockey repeated sprint test performance. Therefore, CT could be utilized punctually to improve repeated sprint performance of elite hockey players as it could potentially help create odd man rushes during games.